J F Fléjou1, V Gratio, F Muzeau, R Hamelin. 1. Service d'Anatomie Pathologique, Hôpital Beaujon, Clichy, France. jean-francois.flejou@bjn.ap-hop-paris.fr
Abstract
AIM: To compare the frequency and type of p53 alterations (gene mutation and/or protein overexpression) in a consecutive series of surgically resected adenocarcinomas arising in the gastric cardia and gastric antrum, and to evaluate associations with clinicopathological findings (age, sex, and tumour histology, grade, and stage). METHODS: The series comprised 50 patients with adenocarcinoma of the cardia and 20 patients with adenocarcinoma of the antrum. p53 gene mutations (exons 5-8) were detected by denaturing gradient gel analysis and DNA sequencing. Nuclear p53 overexpression was detected by immunohistochemistry with the DO7 antibody. RESULTS: p53 gene mutations were found in 21 of 50 and five of 20 adenocarcinomas of the cardia and the antrum, respectively. Base transitions occurring at CpG dinucleotides were frequent in both types of tumour. p53 protein overexpression was seen in 32 of 50 and seven of 20 adenocarcinomas of the cardia and of the antrum, respectively. p53 gene mutation and/or protein overexpression were significantly more frequent in adenocarcinomas of the cardia (37 of 50) than in adenocarcinomas of the antrum (seven of 20). There were no differences in the clinicopathological characteristics of the tumours between p53 positive and p53 negative cases in both types of cancer. CONCLUSIONS: This study shows that p53 alterations are more frequent in adenocarcinoma of the cardia than in adenocarcinoma of the antrum. This feature is consistent with the clinical and epidemiological characteristics of these cancers, which suggest that adenocarcinoma arising in the gastric cardia might be related to oesophageal adenocarcinoma, and unrelated to adenocarcinomas of the gastric body and antrum.
AIM: To compare the frequency and type of p53 alterations (gene mutation and/or protein overexpression) in a consecutive series of surgically resected adenocarcinomas arising in the gastric cardia and gastric antrum, and to evaluate associations with clinicopathological findings (age, sex, and tumour histology, grade, and stage). METHODS: The series comprised 50 patients with adenocarcinoma of the cardia and 20 patients with adenocarcinoma of the antrum. p53 gene mutations (exons 5-8) were detected by denaturing gradient gel analysis and DNA sequencing. Nuclear p53 overexpression was detected by immunohistochemistry with the DO7 antibody. RESULTS:p53 gene mutations were found in 21 of 50 and five of 20 adenocarcinomas of the cardia and the antrum, respectively. Base transitions occurring at CpG dinucleotides were frequent in both types of tumour. p53 protein overexpression was seen in 32 of 50 and seven of 20 adenocarcinomas of the cardia and of the antrum, respectively. p53 gene mutation and/or protein overexpression were significantly more frequent in adenocarcinomas of the cardia (37 of 50) than in adenocarcinomas of the antrum (seven of 20). There were no differences in the clinicopathological characteristics of the tumours between p53 positive and p53 negative cases in both types of cancer. CONCLUSIONS: This study shows that p53 alterations are more frequent in adenocarcinoma of the cardia than in adenocarcinoma of the antrum. This feature is consistent with the clinical and epidemiological characteristics of these cancers, which suggest that adenocarcinoma arising in the gastric cardia might be related to oesophageal adenocarcinoma, and unrelated to adenocarcinomas of the gastric body and antrum.
Authors: B Renault; M van den Broek; R Fodde; J Wijnen; N S Pellegata; D Amadori; P M Khan; G N Ranzani Journal: Cancer Res Date: 1993-06-01 Impact factor: 12.701
Authors: P Tanière; G Martel-Planche; D Maurici; C Lombard-Bohas; J Y Scoazec; R Montesano; F Berger; P Hainaut Journal: Am J Pathol Date: 2001-01 Impact factor: 4.307
Authors: Susan Galandiuk; Manuel Rodriguez-Justo; Rosemary Jeffery; Anna M Nicholson; Yong Cheng; Dahmane Oukrif; George Elia; Simon J Leedham; Stuart A C McDonald; Nicholas A Wright; Trevor A Graham Journal: Gastroenterology Date: 2011-12-13 Impact factor: 22.682
Authors: C J Buskens; A Sivula; B P van Rees; C Haglund; G J A Offerhaus; J J B van Lanschot; A Ristimäki Journal: Gut Date: 2003-12 Impact factor: 23.059
Authors: Cathy Bennett; Paul Moayyedi; Douglas A Corley; John DeCaestecker; Yngve Falck-Ytter; Gary Falk; Nimish Vakil; Scott Sanders; Michael Vieth; John Inadomi; David Aldulaimi; Khek-Yu Ho; Robert Odze; Stephen J Meltzer; Eamonn Quigley; Stuart Gittens; Peter Watson; Giovanni Zaninotto; Prasad G Iyer; Leo Alexandre; Yeng Ang; James Callaghan; Rebecca Harrison; Rajvinder Singh; Pradeep Bhandari; Raf Bisschops; Bita Geramizadeh; Philip Kaye; Sheila Krishnadath; M Brian Fennerty; Hendrik Manner; Katie S Nason; Oliver Pech; Vani Konda; Krish Ragunath; Imdadur Rahman; Yvonne Romero; Richard Sampliner; Peter D Siersema; Jan Tack; Tony C K Tham; Nigel Trudgill; David S Weinberg; Jean Wang; Kenneth Wang; Jennie Y Y Wong; Stephen Attwood; Peter Malfertheiner; David MacDonald; Hugh Barr; Mark K Ferguson; Janusz Jankowski Journal: Am J Gastroenterol Date: 2015-04-14 Impact factor: 10.864
Authors: Hector H Li-Chang; Katayoon Kasaian; Ying Ng; Amy Lum; Esther Kong; Howard Lim; Steven Jm Jones; David G Huntsman; David F Schaeffer; Stephen Yip Journal: BMC Cancer Date: 2015-02-06 Impact factor: 4.430
Authors: Hee Jin Kim; Nayoung Kim; Hyuk Yoon; Yoon Jin Choi; Ju Yup Lee; Yong Hwan Kwon; Kichul Yoon; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Hye Seung Lee; Dong Ho Lee Journal: Gut Liver Date: 2016-03 Impact factor: 4.519
Authors: Anthony C Wood; Yonghong Zhang; Qianxing Mo; Ling Cen; Jacques Fontaine; Sarah E Hoffe; Jessica Frakes; Sean P Dineen; Jose M Pimiento; Christine M Walko; Rutika Mehta Journal: Oncologist Date: 2022-04-05